Iomazenil

Iomazenil is a benzodiazepine antagonist used in the treatment of benzodiazepine overdoses. It is marketed under the brand name Anexate but only in certain countries. Iomazenil is not approved for marketing in the United States, but it has been studied clinically.

Etymology[edit | edit source]

The name "Iomazenil" is derived from its chemical structure, which is a benzodiazepine derivative. The "Io" prefix is derived from the Greek word "ion", meaning "going", which refers to its ability to reverse the effects of benzodiazepines. The "mazenil" suffix is common to other benzodiazepine antagonists, such as flumazenil.

Pharmacology[edit | edit source]

Iomazenil, like other benzodiazepine antagonists, works by binding to the benzodiazepine site on the GABA_A receptor and preventing the action of benzodiazepines and related drugs. It has a high affinity for the benzodiazepine receptor, but it does not have any intrinsic activity, so it does not produce any effects on its own. Instead, it blocks the effects of other drugs that act on the benzodiazepine receptor.

Clinical use[edit | edit source]

Iomazenil is used in the treatment of benzodiazepine overdoses. It can reverse the sedation and respiratory depression that are often seen in these cases. However, it does not reverse other effects of benzodiazepines, such as amnesia or muscle relaxation.

Side effects[edit | edit source]

The most common side effects of iomazenil are dizziness, headache, and nausea. These are usually mild and transient. More serious side effects can occur, including seizures, especially in patients with a history of epilepsy or other seizure disorders.

See also[edit | edit source]

Iomazenil Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.